"Smoker's paradox" and reperfusion's strategy in acute myocardial infarction;« Paradoxe des fumeurs » et stratégie de reperfusion à la phase aiguë de l'infarctus du myocarde

Annales de Cardiologie et d'Angeiologie

Volumn 59, Issue 4, 2010, Pages 183-189

  Addad, F ^a   Dridi, Z ^a   Jemmali, M ^a   Mzoughi, K ^a   Hassine, M ^a   Ghrissi, I ^a   Hamdi, S ^a   Mahjoub, M ^a   Betbout, F ^a   Ben Farhat, M ^a   Gamra, H ^a  

^a FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

Myocardial infarction; Primary angioplasty; Thrombolysis; Tobacco

Indexed keywords

STREPTOKINASE; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; ANTERIOR MYOCARDIAL INFARCTION; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PROGNOSIS; SMOKING; TRANSLUMINAL CORONARY ANGIOPLASTY; AGED; CARDIOGENIC SHOCK; COMPARATIVE STUDY; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE REPERFUSION; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; TUNISIA;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTICOAGULANTS; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SHOCK, CARDIOGENIC; SMOKING; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; TUNISIA;

EID: 77956614384     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2010.07.006     Document Type: Article

References (30)

1. Burke A.P., Farb A., Malcom G.T., Liang Y.H., Smialek J., Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997, 336:1276-1282.
2. Barbash G.I., Reiner J., White H.D., Wilcox R.G., Armstrong P.W., Sadowski Z., et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the " smoker's paradox" from the Gusto-I trial, with angiographic insights. Global utilization of streptokinase and tissue-plasminogen activator for occluded coronary arteries. J Am Coll Cardiol 1995, 26:1222-1229.
3. Andrikopoulos G.K., Richter D.J., Dilaveris P.E., et al. In-hospital mortality of habitual cigarette smokers after acute myocardial infarction; the " smoker's paradox" in a countrywide study. Eur Heart J 2001, 22:776-784.
4. Grines C.L., Topol E.J., O'Neill W.W., George B.S., Kereiakes D., Phillips H.R., et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 1995, 91:298-303.
5. Zahger D., Cercek B., Cannon C.P., Jordan M., Davis V., Braunwald E., et al. How do smokers differ from nonsmokers in their response to thrombolysis? (The TIMI-4 trial). Am J Cardiol 1995, 75:232-236.
6. Lundergan C.F., Reiner J.S., McCarthy W.F., Coyne K.S., Califf R.M., Ross A.M. Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. Global utilization of streptokinase and t-pa for occluded coronary arteries. J Am Coll Cardiol 1998, 32:641-647.
7. Ishihara M., Sato H., Tateishi H., Kawagoe T., Shimatani Y., Kurisu S., et al. Clinical implications of cigarette smoking in acute myocardial infarction: acute angiographic findings and long-term prognosis. Am Heart J 1997, 134:955-960.
8. De Chillou C., Riff P., Sadoul N., Ethevenot G., Feldmann L., Isaaz K., et al. Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis. J Am Coll Cardiol 1996, 27:1662-1668.
9. Himbert D., Juliard J.M., Golmard J.L., Feldman L.J., Aubry P., Benamer H., et al. Révision du « paradoxe du fumeur »: le tabac n'est pas un facteur de bon pronostic au décours immédiat de l'infarctus du myocarde. Arch Mal Cœur Vaiss 2001, 94:262-268.
10. Maggioni A.P., Piantadosi F., Tognoni G., Santoro E., Franzosi M.G. Smoking is not a protective factor for patients with acute myocardial infarction: the viewpoint of the Gissi-2 study. G Ital Cardiol 1998, 28:970-978.
11. Hasdai D., Lerman A., Rihal C.S., Criger D.A., Garratt K.N., Betriu A., et al. Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction. Am Heart J 1999, 137:612-620.
12. Weisz G., Cox D.A., Garcia E., Tcheng J.E., Griffin J.J., Guagliumi G., et al. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction--the smoker's paradox revisited. Am Heart J 2005, 150:358-364.
13. Bowers T.R., Terrien E.F., O'Neill W.W., Sachs D., Grines C.L. Effect of reperfusion modality on outcome in nonsmokers and smokers with acute myocardial infarction (a primary angioplasty in myocardial infarction [PAMI substudy]). PAMI investigators. Am J Cardiol 1996, 78:511-515.
14. Van de Werf F., Bax J., Betriu A., Blomstrom-Lundqvist C., Crea P., Falk V., et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J 2008, 23:2909-2945.
15. Hung J., Lam J.Y., Lacoste L., Letchacovski G. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation 1995, 92:2432-2436.
16. Addad F., Gamra H., Ben Farhat M., Dridi Z., Ben Hamda K., Betbout F., et al. Particularités cliniques, thérapeutiques et pronostiques de l'infarctus du myocarde chez le sujet âgé de plus de 75 ans. Cardiologie tunisienne 2006, 1:24-30.
17. Jorgensen, Kober L., Ottesen M.M., Torp-Pedersen C., Videbaek J., Kjoller E. The prognostic importance of smoking status at the time of acute myocardial infarction in 6676 patients. Trace study group. J Cardiovasc Risk 1999, 6:23-27.
18. Purcell I.F., Newall N., Farrer M. Lower cardiac mortality in smokers following thrombolysis for acute myocardial infarction may be related to more effective fibrinolysis. QJM 1999, 92:327-333.
19. Kievit P.C., Brouwer M.A., Veen G., Aengevaeren W.R., Verheugt F.W. The smoker's paradox after successful fibrinolysis: reduced risk of reocclusion but no improved long-term cardiac outcome. J Thromb Thrombolysis 2009, 27(4):385-393. Epub 2008 Jun 26.
20. Ikonomidis I., Lekakis J., Vamvakou G., Andreotti F., Nihoyannopoulos P. Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. Am Heart J 2005, 149:832-839.
21. Gomez M.A., Karagounis L.A., Allen A., Anderson J.L. Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. Team-2 investigators. Second multicenter thrombolytic trials of eminase in acute myocardial infarction. Am J Cardiol 1993, 72:373-378.
22. Bongard V., Puel J., Savary D., Belle L., Charpentier S., Cottin Y., et al. Predictors of infarct artery patency after prehospital thrombolysis: the multicentre, prospective, observational OPTIMAL study. Heart 2009, 95(10):799-806.
23. Barbash G.I., White H.D., Modan M., Diaz R., Hampton J.R., Heikkila J., et al. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the international tissue plasminogen activator/streptokinase mortality trial. Circulation 1993, 87:53-58.
24. Himbert D., Klutman M., Steg G., White K., Gulba D.C. Cigarette smoking and acute coronary syndromes: a multinational observational study. Int J Cardiol 2005, 100:109-117.
25. Lee K.L., Woodlief L.H., Topol E.J., Weaver W.D., Betriu A., Col J., et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. Gusto-I investigators. Circulation 1995, 91:1659-1668.
26. Mueller H.S., Cohen L.S., Braunwald E., Forman S., Feit F., Ross A., et al. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II. Circulation 1992, 85:1254-2126.
27. Allen R.A., Kluft C., Brommer E.J. Effect of chronic smoking on fibrinolysis. Arteriosclerosis 1985, 5:443-450.
28. Katayama T., Iwasaki Y., Sakoda N., Yoshioka M. The etiology of " smoker's paradox" in acute myocardial infarction with special emphasis on the association with inflammation. Int Heart J 2008, 49(1):13-24.
29. Addad F., Chakroune T., Ayed A., Abderazek F., Dridi Z., Ghrissi I., et al. Clopidogrel but not aspirin prevents acute smoking-induced platelet aggregation in patients with stable coronary artery disease. Thromb Res 2009, 123(4):640-643.
30. Fisher M. The smoking-thrombolysis paradox and acute ischemic stroke. Neurology 2006, 66(3):458.